Pramiracetam, also known as CI-879, is another chemical relative to piracetam, and has a similar effect in improving the operations of the neurotransmitter acetylcholine. Like oxiracetam, pramiracetam appears to be more potent than piracetam. Although pramiracetam seems to be more potent and effective, it is less common than piracetam. Pramiracetam is newer, less tested, and less available.
Parke Davis is working through the maze of FDA approval of pramiracetam to treat Alzheimer’s disease. If pramiracetam becomes legally available, it will probably be used not only for Alzheimer’s disease but for cognitive enhancement as well.
